{
  "abstract": "Claiming that gabapentin prescription increases the risk of dementia and cognitive impairment” implies causality. Establishing causality is a central objective of clinical research, and the gold standard for determining causality is the randomized controlled trial (RCT). However, not all questions can be answered by an RCT and propensity-score analyses (PSA) aim to use observational data to recreate the RCT structure, by balancing known covariates. While PSAs are an advanced statistical technique, methodological shortcomings in the PSA published by Eghrari et al1 should be addressed, especially considering the potential detrimental impact this article may have on patient care.",
  "authors": [
    {
      "affiliations": [
        "Anesthesiology and Pain Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"
      ],
      "name": "James Khan"
    },
    {
      "affiliations": [
        "Anesthesiology and Pain Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"
      ],
      "name": "Rhyall William Sinclair Hughes"
    },
    {
      "affiliations": [
        "Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark"
      ],
      "name": "Tri-Long Nguyen"
    }
  ],
  "title": "Re: ‘Risk of dementia following gabapentin prescription in chronic low back pain patients’",
  "uid": "6662ae7f-26ee-5dba-9da0-1e47f119d7b8"
}